Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer (original) (raw)
References
Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53:3241 Google Scholar
Coombs LM, Oliver S, Sweeney E, Knowles M (1993) Immuno-cytochemical localization of c-erbB2 protein in transitional cell carcinoma of the urinary bladder. J Pathol 168:35 Google Scholar
Cordon-Cardo C, Wartinger D, Petrylack D, Dalbagni G, Fair WF, Fuks Z, Renter VE (1992) Altered expression of retinobastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256 Google Scholar
DePotter CR, Beghin C, Makar AP, Vandekerchkhove D, Roels HJ (1990) The neurooncogene protein as a predictive factor for hematogenous metastases in breast cancer patients. Int J Cancer 45:55 Google Scholar
DiMarco E, Pierce JH, Aaronson SA, DiFiore PP (1990) Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. Nat Imm Cell Reg 9:209 Google Scholar
Fradet Y (1990) Biological markers of prognosis in invasive bladder cancer. Semin Oncol 17:533 Google Scholar
Fukuyama R, Shimizu N (1991) Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues. J Exp Zool 258:336 Google Scholar
Gates RE, King LE, Jr (1985) Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites. Biochemistry 24:5209 Google Scholar
Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LWK (1993) Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 53:5300 Google Scholar
Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD (1992) Identification of heregulin, a specific activator of p185 erbB2. Science 256:1205 Google Scholar
International Union Against Cancer (1987) TNM classification of malignant tumors, 4th edn. SpringerBerlin Heidelberg New York Google Scholar
Klijn JG, Berns PM, Schmitz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review of 5232 patients. Endocr Rev 13:3 Google Scholar
Lau JLT, Fowler JE, Jr, Ghosh L (1988) Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol 139:170 Google Scholar
Limas C (1991) Relationship of epidermal growth factor receptor deductibility with the A,B,H blood group antigens: Emphasis on normal and neoplastic urothelium. Am J Pathol 139:131 Google Scholar
Limas C, Bair R, Bernhart P (1993) Reddy P proliferation activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. J Clin Pathol 46:810 Google Scholar
Lipponen P (1993) Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53:365 Google Scholar
Lipponen P (1993) Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 29A:749 Google Scholar
Marth C, Lang T, Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Dazembichler G (1992) Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells. Int J Cancer 52:311 Google Scholar
McCann A, Dervan PA, Johnston PA, Gullick WJ, Carney DN (1990) c-erbB-2 oncoprotein expression in primary human tumors. Cancer 65:88 Google Scholar
Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530 Google Scholar
Messing EM, Reznikoff CA (1987) Normal and malignant human urothelium: In vitro effects of epidermal growth factor. Cancer Res 47:2230 Google Scholar
Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katzuta N, Mori S (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 145:423 Google Scholar
Mostofi FK, Sobin HL, Torlini H (1973) Histologic typing of urinary bladder tumors. World Health Organization, Geneva Google Scholar
Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365 Google Scholar
Neal DE, Bennett MK, Hall RR, Marsh C, Abel P, Sainsbury JRC (1985) Epidermal growth factor receptors in human bladder cancer: Composition of invasive and superficial tumours. Lancet I:366 Google Scholar
Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619 Google Scholar
Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Zhang G, Singleton TP, Ward S, Dykoski D, Harvey J, Nichans GA (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am J Clin Pathol 101:166 Google Scholar
Nickell KA, Halper J, Moses HL (1983) Transforming growth factors in solid human malignant neoplasms. Cancer Res 43:1966 Google Scholar
Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54:2771 Google Scholar
Sainsbury JRC, Malcom AJ, Appleton DR, Farndon JR, Harris AL (1985) Presence of EGF-R as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225 Google Scholar
Sato K, Moriyama M, Mori S, Saito M, Watanuki T, Terada K, Okuhara E, Akiyama T, Toyoshima K, Yamamoto T, Kato T (1992) An immunohistologic evaluation of c-iterbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493 Google Scholar
Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ (1994) Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508 Google Scholar
Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High molecular weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 43:403 Google Scholar
Swanson PE, Frierson HF, Jr, Wick MR (1992) c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized high grade transitional cell carcinoma of the bladder. Mod Pathol 5:531 Google Scholar
Tribukait B, Gustafson H, Esposti PL (1982) The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors: A study of 100 untreated cases. Br J Urol 54:130 Google Scholar
Visscher DW, Castellani R, Wykes SM, Sarkar FH, Hussain ME (1993) Concurrent abnormal expression of ERBB-2, EGFR and p53 genes and clinical progression of breast carcinoma. Br Cancer Res Treat 28:261 Google Scholar
Wood DP, Jr, Wartinger DD, Reuter V, Cordon-Cardo C, Fair WR, Chaganti SK (1991) DNA, RNA and immunohistochemical characterization of the_HER-2/neu_ oncogene in transitional cell carcinoma of the bladder. J Urol 146:1398 Google Scholar
Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CHW, Neal DE (1991) Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967 Google Scholar
Wright C, Mellon K, Neal DE, Johnson P, Corbett IP, Horne CHW (1990) Expression of c-erbB-2 (neu) protein product in bladder cancer. Br J Cancer 62:764 Google Scholar